SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NNVC - NanoViricides, Inc.
NNVC 1.660-2.4%Oct 31 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Straynut who wrote (7202)8/16/2016 11:00:16 AM
From: Magnus11 Recommendation

Recommended By
drkaz

   of 12871
 
Thanks Straynut...it's a great article on the direction of the technology...looking forward to the WP & B results and how the market responds...this new tech raises challenges that can't be anticipated or known...but NNVC has met their challenges so far...the biggest being not able to find a reliable third party manufacture the micelles to requirements. Those unable to absorb new information are still posting the old time line when NNVC reasonably thought they would be able to contract a third party. Creating their own manufacturing facility delayed everything but will be worth it in end...it's a long road to have too design and create your own facility, teach the testers how to test your product, and then ultimately educate the FDA on the new tech...it's a new paradigm in medicine (and the current time line on NNVC website reflects that reality). But it's the right course to take. Once these entities understand the new paradigm things will move quickly...tipping point approaching...thanks for the post.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext